A deep learning-generated hASIC1a miniprotein inhibitor confers neuroprotection in stroke
In the authors' words
Ion channels remain notoriously recalcitrant drug targets despite their extensive pathophysiological significance. Acid-sensing ion channels (ASICs) are proton-gated cation channels that cause neuronal death when excessively activated, such as during ischaemic stroke. This acidosis-driven injury pathway remains unchallenged by existing therapeutics. Here we generate two de novo designed hASIC1a-specific miniproteins by developing a platform that integrates computational miniprotein design, high-throughput automated patch clamp screening, biophysical and structural characterisation, and in vivo validation. We identify a subtype-selective hASIC1a inhibitor, Denasin1, which achieves near-complete inhibition with nanomolar potency. Denasin1 is disordered in solution but adopts the computationally predicted helix-turn-helix fold when bound to the extracellular acidic pocket of hASIC1a. Crucially, Denasin1 reduces infarct volume by > 50% in a murine model of ischaemic stroke. We thereby establish our de novo design platform as a route to develop potent and selective ion channel modulators.
In plain words AI summary
Acid-sensing ion channels cause brain cell death when overactivated during stroke. The researchers created two new miniproteins that specifically target the human ASIC1a channel using computer design and lab testing. One miniprotein, named Denasin1, strongly blocks the channel with nanomolar potency. Denasin1 reduced stroke damage by more than 50% in mice. This work shows their design platform can develop powerful and selective ion channel drugs.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.
Appeared: Saturday, October 10. bioRxiv. Preprint, not yet peer-reviewed.